Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Advances|July 9, 2026
Neuron-specific WWOX gene therapy produces dose-dependent, durable rescue in a model of WWOX-related epileptic encephalopathyMustafa Obeid, Rania Akkawi, Srinivasarao Repudi, et al.
Vaccine|May 28, 2024
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccinesYaniv Lustig, Noam Barda, Yael Weiss-Ottolenghi, et al.
Emerging Infectious Diseases|April 26, 2024
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023Yaniv Lustig, Michal Canetti, Victoria Indenbaum, et al.
Plos One|August 8, 2012
Deep Panning: steps towards probing the IgOmeArie Ryvkin, Haim Ashkenazy, Larisa Smelyanski, et al.
Vaccines|November 24, 2022
Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5-11 YearsGili Joseph, Elisheva Klein, Yaniv Lustig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2022
The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionNoam Barda, Michal Canetti, Mayan Gilboa, et al.
Viruses|January 8, 2025
Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort StudyGili Joseph, Ili Margalit, Yael Weiss-Ottolenghi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 30, 2022
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022Noam Barda, Michal Canetti, Mayan Gilboa, et al.
Nature Communications|December 13, 2022
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.
Viruses|December 23, 2022
High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant RecipientsYana Davidov, Victoria Indenbaum, Nofar Atari, et al.
Pageof 5